Back to 
Cubist Systematic Strategies, LLC
Cubist Systematic Strategies, LLC
DBTX
Showing 0 of 4 quarters
Position history for Cubist Systematic Strategies, LLC's holdings in Decibel Therapeutics Inc
No. Cubist Systematic Strategies exited its DBTX (Decibel Therapeutics) position in Q3 2023. Its Q2 2023 13F listed 10 shares worth $39. Cubist Systematic Strategies first reported DBTX in Q4 2022 and held it in 3 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of DBTX: Citadel Advisors LLC, Alphabet Inc.